User banner image
User avatar
  • admin

Posts

ELF DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – ELF

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc....

Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test

Comprehensive epigenomic platform enables systematic and quantitative prediction of tumor gene expression from cell-free DNA Genes include key targets for next generation precision medicines, such...

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development...

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization...

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting

Zoldonrasib, a RAS(ON) G12D-selective inhibitor, demonstrated acceptable tolerability and encouraging initial antitumor activity in patients with previously treated KRAS G12D mutant non-small cell lung cancer...

Mitolyn Reviews: DO NOT Spend A Dime Until You’ve Read This Report?

The weight loss revolution : Mitolyn’s Mitochondrial Mastery System Delivers Sustainable Fat Burning Together with Increased Energy Levels Albany, New York, April 27, 2025 (GLOBE...

Everest Medicines Announces the “B” Marker Removal from Company’s Stock Code, Effective May 2, 2025

SHANGHAI, April 28, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization...

Hikvision releases 2024 ESG report, delivering THRIVE for a better future

HANGZHOU, China, April 27, 2025 /PRNewswire/ — Hikvision has published its 2024 Environmental, Social and Governance (ESG) Report, marking seven consecutive years of sharing its...

Hikvision releases 2024 full-year and 2025 first-quarter financial results

HANGZHOU, China, April 27, 2025 /PRNewswire/ — Hikvision has announced its full-year financial results for 2024 and first-quarter results for 2025. In 2024, the company reported...

Hikvision releases 2024 full-year and 2025 first-quarter financial results

HANGZHOU, China, April 27, 2025 /PRNewswire/ — Hikvision has announced its full-year financial results for 2024 and first-quarter results for 2025. In 2024, the company reported...